Gitoformate

Jump to navigation Jump to search
Gitoformate
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC46H64O19
Molar mass920.989 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Gitoformate (INN, or pentaformylgitoxin, trade name Dynocard) is a cardiac glycoside, a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat).[1] Produced by Madaus, it is not available in the US, and does not seem to be available in Europe either.

Chemistry

Gitoformate is a derivative of the glycoside gitoxin, with five of the six free hydroxyl groups formylated, one on the aglycon and four on the sugar.[2][3] Gitoxin, a cardiac glycoside from the Woolly Foxglove (Digitalis lanata), has an aglycon of the cardenolide type named gitoxigenin, which is also the aglycon of lanatoside B, another Digitalis lanata glycoside.[4]

References

  1. PMID 6541927 (PMID 6541927)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  2. PMID 6542412 (PMID 6542412)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  3. Template:PubChem
  4. William O. Foye,Thomas L. Lemke, David A. Williams. Foye's principles of medicinal chemistry. p. 699. ISBN 978-0-7817-6879-5.

Template:Cardiac glycosides


Template:WikiDoc Sources